Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0QL3P
|
||||
| Former ID |
DAP000528
|
||||
| Drug Name |
Oxcarbazepine
|
||||
| Synonyms |
Epilexter; Epliga; Oxacarbazepine; Oxcarbamazepine; Oxcarbazepime; Oxcarbazepina; Oxcarbazepinum; Timox; Trileptal; Desitin brand of oxcarbazepine; Novartis brand of oxcarbazepine; Oxcarbazepine [INN]; GP 47680; O0363; GP-47680; KIN-493; Oxaleptal (TN); Oxcarbazepina [INN-Spanish]; Oxcarbazepinum [INN-Latin]; SPN-804; Trileptal (TN); Oxcarbazepine (USAN/INN); 10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide; 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticonvulsants
|
||||
| Company |
Norvatis Phamaceuticals Corporation
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H12N2O2
|
||||
| InChI |
InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)
|
||||
| InChIKey |
CTRLABGOLIVAIY-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 28721-07-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9695, 866068, 866523, 7784956, 7847599, 7980216, 8173559, 11364569, 11367131, 11369693, 11372776, 11374387, 11377855, 11484081, 11488299, 11491484, 11492449, 11495489, 11528646, 12013820, 15196775, 24724563, 26612687, 26679796, 26719673, 26747194, 26747195, 34676003, 46386767, 46507580, 47291388, 47365462, 50085868, 50105170, 53790510, 57311661, 75522661, 81040908, 81093135, 87561105, 92124721, 92307920, 92308514, 92309109, 92711414, 93166236, 96099912, 99233256, 99437127, 103292787
|
||||
| SuperDrug ATC ID |
N03AF02
|
||||
| SuperDrug CAS ID |
cas=028721075
|
||||
| Target and Pathway | |||||
| Target(s) | Voltage-gated sodium channel | Target Info | Blocker | [536568], [536983] | |
| References | |||||
| Ref 536756 | Use of second-generation antiepileptic drugs in the pediatric population. Paediatr Drugs. 2008;10(4):217-54. | ||||
| Ref 542272 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7254). | ||||
| Ref 536568 | Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22(1):27-47. | ||||
| Ref 536983 | Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all. Epilepsia. 2008 Dec;49 Suppl 9:13-24. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.